Compile Data Set for Download or QSAR
Report error Found 89 Enz. Inhib. hit(s) with all data for entry = 50007355
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061849(2-Benzenesulfonylamino-3-{3-[(5-carbamimidoyl-benz...)
Affinity DataIC50: 1.80nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061840((S)-3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061839(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061862((S)-3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061847((S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimid...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061859(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061848(3-{3-[(5-Carbamimidoyl-1H-indole-2-carbonyl)-methy...)
Affinity DataIC50: 20nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061841(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 20nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061864(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 20nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061862((S)-3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 25nMAssay Description:Inhibition of 20 uM ADP-induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061849(2-Benzenesulfonylamino-3-{3-[(5-carbamimidoyl-benz...)
Affinity DataIC50: 35nMAssay Description:Inhibition of 20 uM ADP-induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061847((S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimid...)
Affinity DataIC50: 35nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061869((S)-2-Amino-3-{3-[(5-carbamimidoyl-benzofuran-2-ca...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061843(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061838(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061853(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061845(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061839(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 50nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061859(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 53nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061854(2-(Butane-1-sulfonylamino)-3-{3-[(6-carbamimidoyl-...)
Affinity DataIC50: 55nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061840((S)-3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 65nMAssay Description:Inhibition of 20 uM ADP-induced platelet aggregation in human platelet-rich plasmaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061865(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 100nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061855(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 125nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061846(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-meth...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061837(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061869((S)-2-Amino-3-{3-[(5-carbamimidoyl-benzofuran-2-ca...)
Affinity DataIC50: 200nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061851(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061843(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 200nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061837(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 250nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061846(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-meth...)
Affinity DataIC50: 250nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061853(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 250nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061868(3-{[1-(5-Carbamimidoyl-benzofuran-2-carbonyl)-pipe...)
Affinity DataIC50: 250nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061864(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 280nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061850(3-{2-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 300nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061855(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 300nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061845(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 300nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061838(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 300nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061865(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 350nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061868(3-{[1-(5-Carbamimidoyl-benzofuran-2-carbonyl)-pipe...)
Affinity DataIC50: 400nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061844(3-{[2-(5-Carbamimidoyl-benzofuran-2-carbonyl)-1,2,...)
Affinity DataIC50: 500nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061851(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061841(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061863(3-{3-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 600nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061866(3-{3-[(6-Carbamimidoyl-1H-indazole-3-carbonyl)-ami...)
Affinity DataIC50: 630nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061857(3-{3-[(5-Carbamimidoyl-1H-indole-2-carbonyl)-amino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061852(3-{[(R)-1-(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061858(3-{3-[(6-Carbamimidoyl-1H-indole-2-carbonyl)-amino...)
Affinity DataIC50: 1.35E+3nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061852(3-{[(R)-1-(5-Carbamimidoyl-benzofuran-2-carbonyl)-...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061850(3-{2-[(5-Carbamimidoyl-benzofuran-2-carbonyl)-amin...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061867(3-{3-[(6-Carbamimidoyl-1H-indole-3-carbonyl)-amino...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of platelet aggregation induced by 20 uM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 89 total ) | Next | Last >>
Jump to: